Summary & Overview
HCPCS E2104: Home Blood Glucose Monitor with Integrated Lancing/Test Cartridge
HCPCS Level II code E2104 identifies a home-use blood glucose monitor that operates with an integrated lancing and blood-sample testing cartridge. The code captures durable medical equipment used by patients to self-monitor glucose levels outside clinical settings, supporting diabetes management and care coordination. Nationally, access to standardized billing codes for such integrated monitors matters for consistent coverage determinations, supplier reimbursement, and patient access to user-friendly glucose testing technologies.
Key payers considered include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise explanation of what E2104 represents, comparisons of payer coverage approaches, common billing modifiers and their relevance, and clinical context around home glucose monitoring devices. The publication also outlines typical sites of service, coding caveats, and where data was unavailable.
This summary is intended for billing professionals, durable medical equipment suppliers, and clinical program managers seeking clarity on coding, coverage patterns, and operational considerations tied to integrated home glucose monitors.
Billing Code Overview
HCPCS Level II code E2104 describes a home blood glucose monitor designed for use with an integrated lancing/blood sample testing cartridge. This device combines a single unit for lancing and blood capture with a compatible glucose test cartridge system.
-
Service type: Durable medical equipment for home glucose monitoring
-
Typical site of service: Patient residence; device intended for at-home self-monitoring of blood glucose
Clinical & Coding Specifications
Clinical Context
A typical patient is an adult with diabetes mellitus who requires home blood glucose monitoring to manage glycemic control. The clinician (primary care physician, endocrinologist, or advanced practice provider) prescribes a home blood glucose monitor designed for use with an integrated lancing/blood sampling testing cartridge (E2104). The device is provided to the patient in the outpatient clinic or at discharge from an observation or inpatient stay to enable capillary blood glucose self-testing.
Workflow:
-
The clinician documents the medical necessity for self-monitoring based on diagnosis, medication regimen (insulin or insulin secretagogues), or poor glycemic control.
-
A medical assistant or diabetes educator demonstrates device operation, cartridge loading, safe lancet disposal, and recording of results.
-
The device
E2104is dispensed or billed through durable medical equipment processes; necessary modifiers may be appended to reflect circumstances (e.g., unexpected complexity or replacement). Patient education and a brief follow-up plan are documented in the medical record. -
Typical site of service is outpatient clinic, home health setting, or hospital discharge for home use. The service supports ongoing diabetes self-management, insulin dose titration, and prevention of hypoglycemia or hyperglycemia-related complications.